E XHIBIT 10.5
PHYSICIANPLUS
™
AGREEMENT
(Branded Products)
This PHYSICIAN PLUS AGREEMENT
(“Agreement”), effective August 15, 2004
(“Effective Date”), is between Hemosense, Inc., a
California corporation with its principal offices located at 651
River Oaks Parkway, San Jose, California 95134, hereinafter called
“SUPPLIER,” and Cardinal Health 200, Inc., a Delaware
Corporation that is the Medical Products and Services Group of
Cardinal Health, with offices located at 1450 Waukegan Road, McGaw
Park, Illinois 60085, hereinafter called
“DISTRIBUTOR.”
BACKGROUND
DISTRIBUTOR works with its physician
customers to provide a broad product offering while helping those
customers make the best possible product choices to maximize their
supply budget dollars. This broad product offering contains, among
other products, PhysicianPlus ™ products. Distributor’s intent is,
through its strategic program called the PhysicianPlus
™
Program, to encourage its physician
customers’ conversion to Distributor’s portfolio of
PhysicianPlus products.
SUPPLIER desires to have certain of
its products (specifically, the “Products” as defined
in Section 1 below) included in the PhysicianPlus Program and
DISTRIBUTOR is willing to include the Products in such program
subject to the terms and conditions of this Agreement.
SUPPLIER and DISTRIBUTOR agree as
follows:
1. Products Covered by this
Agreement; Exclusivity.
The products covered by this
Agreement are those products listed on Schedule “A”
(the “Products”). Products may be added to or deleted
from this Agreement by mutual consent of the parties. SUPPLIER
hereby appoints DISTRIBUTOR as, and DISTRIBUTOR hereby accepts such
appointment as, the exclusive distributor of the Products for
physician offices, clinics and surgery centers in the United States
(the “Customers”). SUPPLIER shall have the right, upon
written notice to DISTRIBUTOR, to terminate this Agreement in the
event DISTRIBUTOR fails to achieve the quarterly order volume
targets as listed in Schedule “B” (the
“Minimums”) and fails to cure such failure by placing a
purchase order for Products an amount necessary to reach such
Minimums within 30 days after written notice from
SUPPLIER.
For so long as DISTRIBUTOR continues
to achieve the Minimums, SUPPLIER shall not appoint any other
person or entity to distribute the Products (or any products with
the same specifications as the Products) to the Customers. SUPPLIER
shall notify DISTRIBUTOR in the event SUPPLIER elects to exercise
its rights to appoint any other distributors as permitted in the
preceding sentence. Notwithstanding anything to the contrary above,
SUPPLIER may, in its sole discretion, (i) solicit orders directly
from and distribute Products directly to Customers without
violating SUPPLIER’s exclusivity obligation described above
(it being understood that SUPPLIER shall use commercially
reasonable efforts to refer all inquiries from Customers regarding
the purchase of Products to DISTRIBUTOR), and (ii) solicit orders
and distribute Products to Customers through Quality Assured
Services without violating SUPPLIER’s exclusivity obligation
described above provided Quality Assured Services is not currently,
and is not for so long as DISTRIBUTOR continues to achieve the
Minimums set forth in this Agreement, authorized to resell the
Products through other distributors and SUPPLIER uses best efforts
to enforce its contractual rights against Quality Assurance
Services as they relate to unauthorized distribution of
Products.
The parties also acknowledge that as
of the Effective Date, SUPPLIER has appointed a third-party
distributor for the skilled nursing-care facility and extended-care
markets. If that distribution agreement is terminated, the parties
shall, upon Distributor’s request, discuss the possibility of
extending the scope of Distributor’s exclusivity under this
Agreement to cover such markets; provided that in any such case
extension of Distributor’s exclusivity would require an
increase in the Minimums described above.
2. Distributor’s
Duties:
DISTRIBUTOR agrees that, during the
term of this Agreement, the Products shall be included in the
PhysicianPlus Program; as such program may be amended from time to
time by DISTRIBUTOR in its sole
|
***
|
|
Confidential
treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission.
Omitted portions have been filed separately with the
Commission.
|
discretion (provided that such amendments shall
in all cases be subject to the limitations of this Agreement). With
regard to the PhysicianPlus Program, DISTRIBUTOR agrees to: (i)
position the Products to its physician and clinic customers as
PhysicianPlus products; (ii) provide financial incentives to its
sales force to sell the Products to Distributor’s physician
customers; (iii) provide focus on the development of marketing
tools and promotions relating to the Products; (iv) assist and
actively cooperate with SUPPLIER in complementary physician
customer-focused promotional activities with regard to the
Products; (v) provide access, when appropriate, to
Distributor’s senior management, regional presidents and
sales staff to facilitate the meeting of mutual objectives; (vi)
maintain such inventory levels of Products as, DISTRIBUTOR in its
sole discretion, deems necessary to meet customary demand; and
(vii) provide SUPPLIER with a rolling 12-month non binding forecast
of anticipated purchases updated quarterly. For purposes of this
Agreement, the determination of whether a particular facility is
classified a “physician” customer shall generally be
based upon the “bill-to” location for that customer.
Notwithstanding the foregoing, SUPPLIER acknowledges that
DISTRIBUTOR reserves the right to classify facilities within
integrated delivery networks or particular group purchasing
organizations as an “acute”, “non-acute” or
“physician” customer based upon the overall composition
and purchasing characteristics of such networks or groups.
DISTRIBUTOR agrees that, for so long as SUPPLIER has not exercised
its rights to appoint additional distributors pursuant to the first
sentence of the second paragraph of Section 1 and SUPPLIER has
complied with requirements of the scope of the exceptions with
regard to DISTRIBUTOR’s exclusive distribution rights as set
forth in the remainder of that paragraph, DISTRIBUTOR will not sell
or promote any third-party point-of-care anti-coagulation products
during the term of this Agreement other than any such products sold
to DISTRIBUTOR by vendors who were selling these types of products
to DISTRIBUTOR as of the Effective Date. SUPPLIER acknowledges and
agrees that (i) except as described above, DISTRIBUTOR is not
prohibited from using, selling or promoting products which are
competitive with the Products and (ii) DISTRIBUTOR has no minimum
purchase obligations under this Agreement, provided that
DISTRIBUTOR acknowledges that its failure to achieve the Minimums
and to cure such failure will give SUPPLIER the right to terminate
this Agreement as described in Section 1 above.
3. Term . The term of this Agreement shall begin on the
Effective Date and shall continue for three (3) years, or until
earlier terminated in accordance with the provisions of Section 6
below. At the end of the term, the parties may renew the Agreement
for successive one (1) year terms on mutual written
agreement.
4. Pricing and Payment
Terms.
a. The prices for Products ordered
by the DISTRIBUTOR shall be as set forth on Schedule A. All such
prices shall remain firm until [***]. Shall a price change be
incurred, SUPPLIER agrees to give DISTRIBUTOR 90 days of
notification, and incorporate such price changes at the start of
the calendar year. Notwithstanding anything to the contrary set
forth herein or in any other agreement between SUPPLIER and
DISTRIBUTOR: (i) payments are due net 30 days from the date of
DISTRIBUTOR’s receipt of Product, (ii) for payments received
within 30 days from the date of DISTRIBUTOR’s receipt of
Product, DISTRIBUTOR shall receive a [***]% discount on such
payment; provided that, upon SUPPLIER’s implementation of EDI
transaction #810, such discount shall only apply where payments are
received within 10 days of the date of DISTRIBUTOR’s receipt
of Product; (iv) SUPPLIER shipments to DISTRIBUTOR’s
locations in the U.S. will be FOB Destination, transportation
expenses included, and (v) to the extent SUPPLIER agrees in its
discretion to expedite Product shipments, (including through Direct
(Drop) shipments to DISTRIBUTOR’s customers) shipment by
SUPPLIER must be F.O.B. Destination, with shipment Prepaid by
SUPPLIER and added to the invoice to DISTRIBUTOR.
b. DISTRIBUTOR and SUPPLIER agree to
work together in good faith to review the opportunity of utilizing
DISTRIBUTOR’s third-party logistics freight program pursuant
to terms to be mutually agreed upon.
c. Distributor shall deduct an
administrative fee of [***]% at the time of invoice payment to
cover the costs of trace sales reports, the rebate process,
contract administration, master merchandise file costs and other
costs to assist with ongoing administration and support of the
program
d. SUPPLIER agrees to the following
process with regard to rebates: DISTRIBUTOR uses an auto-debit
system where rebate dollars are automatically deducted from a
supplier’s payables balance upon the sale to the end-user
customer. Rebate dollars are accumulated until a specified time
period (usually one month) and then the deduction is made. A
remittance advice will follow showing which deductions have been
made.
|
***
|
Confidential
treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission.
Omitted portions have been filed separately with the
Commission.
|
2
e. As additional consideration for
Distributor’s agreement to include the Products in the
PhysicianPlus Program in accordance with the terms and conditions
of this Agreement, SUPPLIER shall pay DISTRIBUTOR an annual volume
growth incentive in the event Distributor’s purchases of
Products (valued at the acquisition cost provided to DISTRIBUTOR
hereunder) in any 12-month period following the Effective Date meet
or exceed the following hurdles:
|
|
|
|
|
Percentage over applicable
Minimum
|
|
Percentage Incentive Paid on Total
Purchases
During Twelve-Month
Period
|
|
[***]%
|
|
[***]%
|
|
[***]%
|
|
[***]%
|
|
[***]%
|
|
[***]%
|
|
[***]% [***]
|
|
[***]%
|
Any volume growth incentive earned
by DISTRIBUTOR will be paid in the form of a check within 30 days
after the close of the applicable 12-month period. If this
agreement is terminated prior to the expiration date, any earned
growth incentives for the final consecutive twelve-month period, if
any, will be prorated for the number of months this agreement was
in effect during such final twelve-month period.
5. Supplier’s
Duties. SUPPLIER
shall:
a. Maintain silver status on
Distributor’s Supply Chain Management Scoreboard, as set
forth on Attachment 1 to this Agreement (attached and incorporated
into this Agreement) (the “Scoreboard”).
b. Provide DISTRIBUTOR, free of
charge, with reasonable quantities of available materials which
would aid in the promotion and sale of the Products.
c. On or before the Effective Date,
provide to DISTRIBUTOR, electronically via Excel or Access or such
other format as the parties shall agree, such competitive cross
referencing information with regard to the Products as DISTRIBUTOR
shall reasonably request and, thereafter, update such information
no less frequently than quarterly.
d. Attend Distributor’s Annual
National Sales Meeting at the then-current PhysicianPlus supplier
rate.
e. Collaborate with DISTRIBUTOR to
review its various businesses and determine other market segment
opportunities for the Products.
f. Provide various promotional
opportunities for DISTRIBUTOR and its sales force, including
without limitation, the “[***]” promotion, at times
mutually agreed upon between the parties.
g. Make any claims for unpaid
invoices in writing within ninety (90) days of the date of
SUPPLIER’s first invoice for such amount. DISTRIBUTOR will
not be obligated to make payments for, or investigate, entries
which are dated more than ninety (90) days before SUPPLIER’s
written claim or request for investigation.
h. On a [***] basis, use
commercially reasonable efforts, in conjunction with DISTRIBUTOR,
to [***]. Excess/no move inventory is any inventory of Products in
a given distribution center that exceeds [***] ([***]) months of
customer demand for that distribution center. “Salable”
Product is defined as undamaged Product in its original sealed
shipping carton.
i. Not impose any item or order
minimums inconsistent with SUPPLIER’s standard terms and
conditions of sale.
|
***
|
Confidential
treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission.
Omitted portions have been filed separately with the
Commission.
|
3
j. Use commercially reasonable
efforts to maintain [***]% Fill Rate (defined below) on all orders
for Products. Fill Rate is defined as complete line items shipped
within [***] hours of receipt of DISTRIBUTOR’s purchase
order.
k. In addition to any electronic
data interchange (EDI) transactions which are required under
DISTRIBUTORR